{Reference Type}: Journal Article
{Title}: Immune monitoring in pediatric kidney transplant.
{Author}: Laroche C;Engen RM;
{Journal}: Pediatr Transplant
{Volume}: 28
{Issue}: 4
{Year}: 2024 Jun
{Factor}: 1.551
{DOI}: 10.1111/petr.14785
{Abstract}: <B>BACKGROUND: </B>Long-term outcomes in pediatric kidney transplantation remain suboptimal, largely related to chronic rejection. Creatinine is a late marker of renal injury, and more sensitive, early markers of allograft injury are an active area of current research.<BR><B>METHODS: </B>This is an educational review summarizing existing strategies for monitoring for rejection in kidney transplant recipients.<BR><B>RESULTS: </B>We summarize supporting currently available clinical tests, including surveillance biopsy, donor specific antibodies, and donor-derived cell free DNA, as well as the potential limitations of these studies. In addition, we review the current avenues of active research, including transcriptomics, proteomics, metabolomics, and torque tenovirus levels.<BR><B>CONCLUSIONS: </B>Advancing the use of noninvasive immune monitoring will depend on well-designed multicenter trials that include patients with stable graft function, include biopsy results on all patients, and can demonstrate both association with a patient-relevant clinical endpoint such as graft survival or change in glomerular filtration rate and a potential timepoint for intervention.